Skip to main content
. 2018 Jul 4;19:783–789. doi: 10.12659/AJCR.909584

Figure 3.

Figure 3.

Positron emission tomography scan demonstrating absence of hypermetabolic activity after 9 months of nivolumab immunotherapy suggestive of complete remission of disease.